What companies are IVBXF's competitors?

Innovent Biologics, Inc. (IVBXF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does IVBXF compare to its peers?

The peer comparison table on this page shows Innovent Biologics, Inc. (IVBXF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does IVBXF operate in?

Innovent Biologics, Inc. (IVBXF) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IVBXF

Innovent Biologics, Inc.

OTC·Biotechnology · Healthcare

$12.80$1.94+17.86%

After hours·$12.80+0.00%

Market cap$22.28B·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About IVBXF

What companies are IVBXF's competitors?: Innovent Biologics, Inc. (IVBXF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IVBXF compare to its peers?: The peer comparison table on this page shows Innovent Biologics, Inc. (IVBXF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IVBXF operate in?: Innovent Biologics, Inc. (IVBXF) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IVBXF

Innovent Biologics, Inc.

OTC·Biotechnology · Healthcare

$12.80$1.94+17.86%

After hours·$12.80+0.00%

Market cap$22.28B·Market closed·Jul 22 8:00 PM UTC

Peers


ALPMY	Astellas Pharma Inc.	$13.30	$23.8B
ALPMF	Astellas Pharma Inc.	$12.85	$23.0B
WXXWY	WuXi Biologics (Cayman) Inc.	$9.91	$20.3B
WXIBF	WuXi Biologics (Cayman) Inc.	$4.60	$19.1B
SUVPF	Sartorius AG	$256.25	$17.7B
GNMSF	Genmab A/S	$274.50	$16.9B
GIKLY	Grifols, S.A.	$5.10	$13.4B
SBMFF	Sino Biopharmaceutical Limited	$0.64	$11.3B
SBHMY	Sino Biopharmaceutical Limited	$12.68	$11.3B
BMXXY	bioMérieux S.A.	$8.03	$9.5B

Frequently Asked Questions About IVBXF

What companies are IVBXF's competitors?: Innovent Biologics, Inc. (IVBXF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IVBXF compare to its peers?: The peer comparison table on this page shows Innovent Biologics, Inc. (IVBXF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IVBXF operate in?: Innovent Biologics, Inc. (IVBXF) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.